Multiple sclerosis genetics

The Lancet Neurology

Volumn 13, Issue 7, 2014, Pages 700-709

  Sawcer, Stephen ^a   Franklin, Robin J M ^a   Ban, Maria ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GLUTAMIC ACID; HLA A ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR;

ALLELE; CALCIUM SIGNALING; CHROMOSOME 1; CLINICAL FEATURE; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETICS; HEREDITY; HERITABILITY; HUMAN; LINKAGE ANALYSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RECURRENCE RISK; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC LINKAGE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84902533644     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70041-9     Document Type: Review

References (113)

1. Compston A, Confavreux C, Lassmann H, et al. McAlpine's multiple sclerosis 2006, Churchill Livingstone, London. 4th edn.
2. Compston A, Coles A Multiple sclerosis. Lancet 2008, 372:1502-1517.
3. Orton SM, Herrera BM, Yee IM, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006, 5:932-936. the Canadian Collaborative Study.
4. Robertson NP, Fraser M, Deans J, Clayton D, Walker N, Compston DA Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996, 119:449-455.
5. O'Gorman C, Lin R, Stankovich J, Broadley SA Modelling genetic susceptibility to multiple sclerosis with family data. Neuroepidemiology 2013, 40:1-12.
6. Simpson S, Blizzard L, Otahal P, Van der Mei I, Taylor B Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 2011, 82:1132-1141.
7. Ahlgren C, Odén A, Lycke J High nationwide prevalence of multiple sclerosis in Sweden. Mult Scler 2011, 17:901-908.
8. Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci USA 2003, 100:12877-12882. the Canadian Collaborative Study.
9. Ebers GC, Sadovnick AD, Risch NJ A genetic basis for familial aggregation in multiple sclerosis. Nature 1995, 377:150-151. the Canadian Collaborative Study.
10. Ebers GC, Yee IM, Sadovnick AD, Duquette P Conjugal multiple sclerosis: population-based prevalence and recurrence risks in offspring. Ann Neurol 2000, 48:927-931. the Canadian Collaborative Study.
11. Dean G, McLoughlin H, Brady R, Adelstein AM, Tallett-Williams J Multiple sclerosis among immigrants in Greater London. BMJ 1976, 1:861-864.
12. Dyment DA, Yee IM, Ebers GC, Sadovnick AD Multiple sclerosis in stepsiblings: recurrence risk and ascertainment. J Neurol Neurosurg Psychiatry 2006, 77:258-259. the Canadian Collaborative Study.
13. Dean G, Yeo TW, Goris A, et al. HLA-DRB1 and multiple sclerosis in Malta. Neurology 2008, 70:101-105.
14. Sawcer S, Ban M, Wason J, Dudbridge F What role for genetics in the prediction of multiple sclerosis?. Ann Neurol 2010, 67:3-10.
15. Guo SW Inflation of sibling recurrence-risk ratio, due to ascertainment bias and/or overreporting. Am J Hum Genet 1998, 63:252-258.
16. Sadovnick AD, Dyment D, Ebers GC Genetic epidemiology of multiple sclerosis. Epidemiol Rev 1997, 19:99-106.
17. Prokopenko I, Montomoli C, Ferrai R, et al. Risk for relatives of patients with multiple sclerosis in central Sardinia, Italy. Neuroepidemiology 2003, 22:290-296.
18. Zuk O, Hechter E, Sunyaev SR, Lander ES The mystery of missing heritability: Genetic interactions create phantom heritability. Proc Natl Acad Sci USA 2012, 109:1193-1198.
19. Al-Chalabi A, Lewis CM Modelling the effects of penetrance and family size on rates of sporadic and familial disease. Hum Hered 2011, 71:281-288.
20. Wang WY, Barratt BJ, Clayton DG, Todd JA Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005, 6:109-118.
21. Risch N, Merikangas K The future of genetic studies of complex human diseases. Science 1996, 273:1516-1517.
22. Willer CJ, Dyment DA, Cherny S, et al. A genome-wide scan in forty large pedigrees with multiple sclerosis. J Hum Genet 2007, 52:955-962.
23. Modin H, Masterman T, Thorlacius T, et al. Genome-wide linkage screen of a consanguineous multiple sclerosis kinship. Mult Scler 2003, 9:128-134.
24. Haghighi S, Andersen O, Nilsson S, Rydberg L, Wahlström J A linkage study in two families with multiple sclerosis and healthy members with oligoclonal CSF immunopathy. Mult Scler 2006, 12:723-730.
25. Dyment DA, Cader MZ, Herrera BM, et al. A genome scan in a single pedigree with a high prevalence of multiple sclerosis. J Neurol Neurosurg Psychiatry 2008, 79:158-162.
26. Olerup O, Hillert J HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991, 38:1-15.
27. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219. The International Multiple Sclerosis Genetics, the Wellcome Trust Case Control Consortium 2the Wellcome Trust Case Control Consortium 2.
28. A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 2005, 77:454-467. The International Multiple Sclerosis Genetics.
29. Naito S, Namerow N, Mickey MR, Terasaki PI Multiple sclerosis: association with HL-A3. Tissue Antigens 1972, 2:1-4.
30. Jersild C, Hansen GS, Svejgaard A, Fog T, Thomsen M, Dupont B Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet 1973, 302:1221-1225.
31. Horton R, Gibson R, Coggill P, et al. Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics 2008, 60:1-18.
32. de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006, 38:1166-1172.
33. Dilthey AT, Moutsianas L, Leslie S, McVean G HLA*IMP-an integrated framework for imputing classical HLA alleles from SNP genotypes. Bioinformatics 2011, 27:968-972.
34. Leslie S, Donnelly P, McVean G A statistical method for predicting classical HLA alleles from SNP data. Am J Hum Genet 2008, 82:48-56.
35. Patsopoulos NA, Barcellos LF, Hintzen RQ, et al. Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet 2013, 9:e1003926. the IMSGC and the.
36. Rubio JP, Bahlo M, Butzkueven H, et al. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Am J Hum Genet 2002, 70:1125-1137.
37. Harbo HF, Lie BA, Sawcer S, et al. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 2004, 63:237-247.
38. Yeo TW, De Jager PL, Gregory SG, et al. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann Neurol 2007, 61:228-236. the International Multiple Sclerosis Genetics Consortium (IMSGC).
39. De Jager PL, Jia X, Wang J, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009, 41:776-782. the International MS Genetics.
40. Marrosu MG, Murru R, Murru MR, et al. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 2001, 10:2907-2916.
41. Dyment DA, Herrera BM, Cader MZ, et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 2005, 14:2019-2026.
42. Barcellos LF, Sawcer S, Ramsay PP, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 2006, 15:2813-2824.
43. Lincoln MR, Ramagopalan SV, Chao MJ, et al. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci USA 2009, 106:7542-7547.
44. Field J, Browning SR, Johnson LJ, et al. A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis. PLoS One 2010, 5:e13454. the Australia and New Zealand Multiple Sclerosis Genetics.
45. Hauser MA, Li YJ, Takeuchi S, et al. Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage. Hum Mol Genet 2003, 12:671-677.
46. Gregory SG, Schmidt S, Seth P, et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007, 39:1083-1091. the Multiple Sclerosis Genetics.
47. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007, 357:851-862. The International Multiple Sclerosis Genetics.
48. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007, 39:1329-1337. The Wellcome Trust Case Control, the Australo-Anglo-American Spondylitis Consortium (TASC)the Australo-Anglo-American Spondylitis Consortium (TASC), the Biologics in RA Genetics and Genomics Study Syndicate (BRAGGS) Steeringthe Biologics in RA Genetics and Genomics Study Syndicate (BRAGGS) Steering, the Breast Cancer Susceptibility Collaboration (UK)the Breast Cancer Susceptibility Collaboration (UK).
49. Comabella M, Craig DW, Camiña-Tato M, et al. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS One 2008, 3:e3490. the BiomarkerMS Study.
50. Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, et al. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet 2008, 40:1402-1403.
51. Baranzini SE, Wang J, Gibson RA, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009, 18:767-778.
52. Bahlo M, Booth D, Broadley S, et al. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009, 41:824-828. the Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene).
53. Sanna S, Pitzalis M, Zoledziewska M, et al. Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet 2010, 42:495-497.
54. Nischwitz S, Cepok S, Kroner A, et al. Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. J Neuroimmunol 2010, 227:162-166.
55. Jakkula E, Leppä V, Sulonen AM, et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 2010, 86:285-291.
56. Patsopoulos NA, Esposito F, Reischl J, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011, 70:897-912. the Bayer Pharma MS Genetics Working, the Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonistthe Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist, the ANZgenethe ANZgene, thethe, the International Multiple Sclerosis Geneticsthe International Multiple Sclerosis Genetics.
57. Matesanz F, González-Pérez A, Lucas M, et al. Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1. PLoS One 2012, 7:e36140.
58. Martinelli-Boneschi F, Esposito F, Brambilla P, et al. A genome-wide association study in progressive multiple sclerosis. Mult Scler 2012, 18:1384-1394.
59. MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis. Brain 2013, 136:1778-1782. The International Multiple Sclerosis Genetics.
60. Lill CM, Schjeide BM, Graetz C, et al. Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk. J Med Genet 2013, 50:140-143.
61. McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008, 9:356-369.
62. Cotsapas C, Voight BF, Rossin E, et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet 2011, 7:e1002254. the FOCiS Network of.
63. Cortes A, Brown MA Promise and pitfalls of the Immunochip. Arthritis Res Ther 2011, 13:101.
64. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013, 45:1353-1360. The International Multiple Sclerosis Genetics Consortium (IMSGC).
65. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74. the ENCODE Project.
66. Maller JB, McVean G, Byrnes J, et al. Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat Genet 2012, 44:1294-1301. the Wellcome Trust Case Control.
67. Refining genetic associations in multiple sclerosis. Lancet Neurol 2008, 7:567-569. International Multiple Sclerosis Genetics Consortium (IMSGC).
68. Sawcer S The complex genetics of multiple sclerosis: pitfalls and prospects. Brain 2008, 131:3118-3131.
69. Yang J, Benyamin B, McEvoy BP, et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet 2010, 42:565-569.
70. Evidence for polygenic susceptibility to multiple sclerosis-the shape of things to come. Am J Hum Genet 2010, 86:621-625. The International Multiple Sclerosis Genetics Consortium (IMSGC).
71. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 2010, 26:2069-2070.
72. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010, 7:248-249.
73. Choi Y, Sims GE, Murphy S, Miller JR, Chan AP Predicting the functional effect of amino acid substitutions and indels. PLoS One 2012, 7:e46688.
74. Ward LD, Kellis M HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 2012, 40:D930-D934.
75. Trynka G, Sandor C, Han B, et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat Genet 2013, 45:124-130.
76. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB Rare variants create synthetic genome-wide associations. PLoS Biol 2010, 8:e1000294.
77. Anderson CA, Soranzo N, Zeggini E, Barrett JC Synthetic associations are unlikely to account for many common disease genome-wide association signals. PLoS Biol 2011, 9:e1000580.
78. Mackie JL The Cement of the Universe: a study in Causation 1988, Clarendon Press, Oxford.
79. Hill AB The Environment and Disease: association or Causation?. Proc R Soc Med 1965, 58:295-300.
80. Visscher PM, Brown MA, McCarthy MI, Yang J Five years of GWAS discovery. Am J Hum Genet 2012, 90:7-24.
81. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007, 39:596-604.
82. Maier LM, Anderson DE, Severson CA, et al. Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses. J Immunol 2009, 182:1541-1547.
83. Gregory AP, Dendrou CA, Attfield KE, et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 2012, 488:508-511.
84. De Jager PL, Baecher-Allan C, Maier LM, et al. The role of the CD58 locus in multiple sclerosis. Proc Natl Acad Sci USA 2009, 106:5264-5269.
85. Couturier N, Bucciarelli F, Nurtdinov RN, et al. Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. Brain 2011, 134:693-703.
86. Hensiek AE, Seaman SR, Barcellos LF, et al. Familial effects on the clinical course of multiple sclerosis. Neurology 2007, 68:376-383.
87. Brynedal B, Wojcik J, Esposito F, et al. MGAT5 alters the severity of multiple sclerosis. J Neuroimmunol 2010, 220:120-124.
88. Genome-wide association study of severity in multiple sclerosis. Genes Immun 2011, 12:615-625. International Multiple Sclerosis Genetics.
89. Baranzini SE, Srinivasan R, Khankhanian P, et al. Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain 2010, 133:2603-2611.
90. Roxburgh RH, Seaman SR, Masterman T, et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005, 64:1144-1151.
91. Buck D, Albrecht E, Aslam M, et al. Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis. Ann Neurol 2013, 73:86-94. the International Multiple Sclerosis Genetics Consortium and the Wellcome Trust Case Control.
92. Goris A, van Setten J, Diekstra F, et al. No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis. Hum Mol Genet 2013, The International Multiple Sclerosis Genetics Consortium and the The Australia and New Zealand MS Genetics, published online Nov 13. 10.1093/hmg/ddt574.
93. Mero IL, Gustavsen MW, Sæther HS, et al. Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles. PLoS One 2013, 8:e58352. the International Multiple Sclerosis Genetics.
94. Leone MA, Barizzone N, Esposito F, et al. Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients. PLoS One 2013, 8:e64408. the International Multiple Sclerosis Genetics, the Wellcome Trust Case Control Consortium 2the Wellcome Trust Case Control Consortium 2, the PROGEMUSthe PROGEMUS, the PROGRESSOthe PROGRESSO.
95. Gourraud PA, Sdika M, Khankhanian P, et al. A genome-wide association study of brain lesion distribution in multiple sclerosis. Brain 2013, 136:1012-1024.
96. Ishii A, Furusho M, Bansal R Sustained activation of ERK1/2 MAPK in oligodendrocytes and schwann cells enhances myelin growth and stimulates oligodendrocyte progenitor expansion. J Neurosci 2013, 33:175-186.
97. Setzu A, Lathia JD, Zhao C, et al. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 2006, 54:297-303.
98. Surolia I, Pirnie SP, Chellappa V, et al. Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature 2010, 466:243-247.
99. Hunt KA, Smyth DJ, Balschun T, et al. Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry. Nat Genet 2012, 44:3-5. the Type 1 Diabetes Genetics, the UK Inflammatory Bowel Disease (IBD) Geneticsthe UK Inflammatory Bowel Disease (IBD) Genetics, the Wellcome Trust Case Controlthe Wellcome Trust Case Control.
100. Abecasis GR, Altshuler D, Auton A, et al. A map of human genome variation from population-scale sequencing. Nature 2010, 467:1061-1073. the 1000 Genomes Project.
101. Ramagopalan SV, Dyment DA, Cader MZ, et al. Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann Neurol 2011, 70:881-886.
102. Cortes A, Field J, Glazov EA, Hadler J, Stankovich J, Brown MA Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes. Hum Mol Genet 2013, 22:2283-2292. the ANZgene.
103. Ban M, Caillier S, Mero IL, et al. No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis. Ann Neurol 2013, 73:430-432.
104. Barizzone N, Pauwels I, Luciano B, et al. No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis. Ann Neurol 2013, 73:433-437.
105. Dyment DA, Cader MZ, Chao MJ, et al. Exome sequencing identifies a novel multiple sclerosis susceptibility variant in the TYK2 gene. Neurology 2012, 79:406-411.
106. Hunt KA, Mistry V, Bockett NA, et al. Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature 2013, 498:232-235.
107. Clayton DG Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet 2009, 5:e1000540.
108. Hemminki K, Li X, Sundquist J, Hillert J, Sundquist K Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics 2009, 10:5-11.
109. Sawcer S, Wason J Risk in complex genetics: "all models are wrong but some are useful". Ann Neurol 2012, 72:502-509.
110. Rose G Sick individuals and sick populations. Int J Epidemiol 1985, 14:32-38.
111. Reich D, Patterson N, De Jager PL, et al. A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet 2005, 37:1113-1118.
112. Lin R, Charlesworth J, Stankovich J, Perreau VM, Brown MA, Taylor BV Identity-by-descent mapping to detect rare variants conferring susceptibility to multiple sclerosis. PLoS One 2013, 8:e56379. the ANZgene.
113. Smith MW, Patterson N, Lautenberger JA, et al. A high-density admixture map for disease gene discovery in African Americans. Am J Hum Genet 2004, 74:1001-1013.